Sun-Hun Kim

Sun-Hun Kim

Auto-generated profile, based on publicly available information

Sun-Hun Kim

Chonnam National University, Republic of Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JKJee-Hae Kang
Jee-Hae Kang
HKHyun-Mi Ko
Hyun-Mi Ko
GHGeum-Dong Han
Geum-Dong Han
SLSu-Young Lee
Su-Young Lee
JMJung-Sun Moon
Jung-Sun Moon
SKSun-Hun Kim
Sun-Hun Kim
Fusion and apoptosis share a breakdown of the membrane phospholipids asymmetry, modes of which are largely unknown in osteoclastogenesis. Here, we investigated the externalization of phosphatidylserine (PS) and its receptors, and their biological functions in osteoclastogenesis. Strong immunoreactivities in vivo for the PS receptors TIM4, BAI1, and STAB2 were observed in the TRAP-positive multinucleated cells in the alveolar bone that was being remodeled around the developing dental follicles in rats. These receptors were significantly upregulated during M-CSF/RANKL-induced in vitro osteoclastogenesis using mouse bone marrow-derived cells. PS externalization in preosteoclasts was increased by the M-CSF/RANKL treatment. Multinucleation of preosteoclasts was markedly inhibited by antibodies against PS and its receptors. Among the investigated lipid transporter proteins, floppases (Abcb4, Abcc5, and Abcg1) were upregulated, whereas flippases (Atp11c and Atp8a1) downregulated during osteoclastogenesis. Preosteoclast fusion was markedly blocked by the ATPase inhibitor Na3VO4 and siRNAs against Abcc5 and Abcg1, revealing the importance of these lipid transporters in PS externalization. Further, the levels of Cd47 and Cd31, don’t-eat-me signal inducers, were increased or sustained in the early phase of osteoclastogenesis, whereas those of AnnexinI and Mfg-e8, eat-me signals inducers, were increased in the late apoptotic phase. In addition, Z-VAD-FMK, a pan caspase inhibitor, had no effect on preosteoclast fusion in the early phase of osteoclastogenesis, whereas Abs against PS, TIM4, and BAI1 decreased osteoclast apoptosis during the late phase. These results suggest that PS externalization is essential for the whole process of osteoclastogenesis and share PS receptors and transporters in the early stage fusion and late stage apoptosis. Therefore, modulation of PS and its receptors could be a useful strategy to develop anti-bone resorptive agents.

25 September 2014 in Journal of Dental Research
Verified
Journal Article
Closed access
JKJ.H. Kang
J.H. Kang
HKH.M. Ko
H.M. Ko
JMJ.S. Moon
J.S. Moon
HYHong Il Yoo
Hong Il Yoo
JJJ.Y. Jung
J.Y. Jung
SKS.H. Kim
S.H. Kim
Osteoprotegerin (OPG) is secreted by stromal and osteoblastic lineage cells and inhibits osteoclastogenesis by preventing the interaction of receptor activator of nuclear factor-κB ligand (RANKL) with receptor activator of nuclear factor-κB (RANK). In this study, the expression of OPG in osteoclasts themselves and its biological functions during osteoclastogenesis were investigated for the first time. OPG expression in vivo in the developing rat maxilla was examined by immunofluorescence analysis. OPG expression in osteoclasts during in vitro osteoclastogenesis was determined by reverse-transcription polymerase chain-reaction (RT-PCR), Western blot, and immunofluorescence staining. We determined the function of OPG produced by osteoclasts during osteoclastogenesis by silencing the OPG gene. The effects of OPG on bone-resorbing activity and apoptosis of mature osteoclasts were examined by the assay of resorptive pit formation on calcium-phosphate-coated plate and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining, respectively. In the immunofluorescence findings, strong immunoreactivities were unexpectedly seen in multinucleated tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts around the growing and erupting tooth germs in the rat alveolar bone. In vitro, OPG expression was significantly increased during the differentiation of osteoclasts from mouse bone-marrow-derived cells treated with a combination of macrophage colony-stimulating factor (M-CSF) and RANKL. Interestingly, it was found that OPG small interfering (si)RNA treatment during osteoclastogenesis enhanced the sizes of osteoclasts, but attenuated their bone-resorbing activity. Also, the increased chromosomal DNA fragmentation and caspase-3 activity in the late phase of osteoclastogenesis were found to be decreased by treatment with OPG siRNA. Furthermore, effects of OPG siRNA treatment on osteoclastogenesis and bone-resorbing activity were recovered by the treatment of exogenous OPG. These results suggest that OPG, expressed by the osteoclasts themselves, may play an auto-regulatory role in the late phase of osteoclastogenesis through the induction of apoptosis.

9 September 2015 in Journal of Dental Research
Verified
Journal Article
Closed access
SLS.Y. Lee
S.Y. Lee
HYHong Il Yoo
Hong Il Yoo
SKS.H. Kim
S.H. Kim
Tooth movement by application of orthodontic biophysical force primarily reflects the role of soluble molecules released from the periodontal ligament (PDL). Thus far, many factors have been reported to be involved in orthodontic tooth movement (OTM), but key molecules that orchestrate responses of periodontal tissues to biophysical force are still enigmatic. In this in vivo study, in which the upper first molars in rats were moved, differential display–polymerase chain reaction revealed that CC chemokine receptor 5 (CCR5) level was differentially increased during OTM. Strong immunoreactivity for CCR5 was found in the PDL undergoing force application. Moreover, the in vitro compression or tension force application to primary cultured human PDL cells increased the expression of CCR5 and CCR5 ligands. In vitro tension force on human PDL cells did not induce RANKL, an osteoclastogenesis-inducing factor, but did induce the upregulation of IL12, an osteoclast inhibitory factor, and osteoblast differentiation factors, including Runx2, which was attenuated under tension by CCR5 gene silencing whereas augmented with CCR5 ligands. In contrast, in vitro compression force did not induce the expression of osteoprotegerin, a decoy receptor for RANKL and Runx2, but did induce the upregulation of RANKL, which was attenuated under compression by CCR5 gene silencing. These results suggest that the CCR5–CCR5 ligands axis in PDL cells may play a crucial role in the remodeling of periodontal tissues and can be a therapeutic target for achieving efficient OTM.

14 March 2013 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
JMJ. S. Moon
J. S. Moon
NCN. R. Cheong
N. R. Cheong
SYS. Y. Yang
S. Y. Yang
IKI. S. Kim
I. S. Kim
HCH. J. Chung
H. J. Chung
HKH. M. Ko
H. M. Ko

11 July 2019 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
JMJung‐Sun Moon
Jung‐Sun Moon
SLSu‐Young Lee
Su‐Young Lee
JKJung‐Ha Kim
Jung‐Ha Kim
YCYoon‐Ho Choi
Yoon‐Ho Choi
DYDong‐Wook Yang
Dong‐Wook Yang
SKSun‐Hun Kim
Sun‐Hun Kim

4 July 2022 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
YNYoo‐Sung Nam
Yoo‐Sung Nam
DYDong‐Wook Yang
Dong‐Wook Yang
JMJung‐Sun Moon
Jung‐Sun Moon
JKJee‐Hae Kang
Jee‐Hae Kang
JCJin‐Hyoung Cho
Jin‐Hyoung Cho
SKSun‐Hun Kim
Sun‐Hun Kim